Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
90
Views
7
CrossRef citations to date
0
Altmetric
Research Article

A Randomized Trial Comparing Intensified CNOP vs. CHOP in Patients with Aggressive Non-Hodgkin's Lymphoma

Gerassimos A. Pangalis Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str., P.O. Box 14044, Athens 11510, Greece
,
Theodoros P. Vassilakopoulos Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str., P.O. Box 14044, Athens 11510, Greece
,
Evridiki Michalis Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str., P.O. Box 14044, Athens 11510, Greece
,
Paraskevi Roussou Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece
,
Effimia Vrakidou Hematology Section, Hygeia Hospital, Athens, Greece
,
Panayiotis Repousis Hematology Clinic, Peripheral General Anticancer Hospital, Metaxa, Piraeus, Greece
,
Maria K. Angelopoulou Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str., P.O. Box 14044, Athens 11510, Greece
,
Marina P. Siakantaris Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str., P.O. Box 14044, Athens 11510, Greece
,
John Korantzis Hematology Clinic, Theagenion Cancer Hospital, Thessaloniki, Greece
,
Argyrios Symeonidis Hematology Division, Department of Internal Medicine, University of Patras, Greece
,
Vassiliki Grigorakis Department of Hematology, General Hospital of Athens, Greece
,
Ekaterini Stefanoudakis Hematology Department, Amalia Fleming General Hospital, Melissia, Greece
,
Marina Stamatellou Hematology Section, Aghios Savas Anticancer Hospital, Athens, Greece
,
Konstantinos L. Bourantas Hematology Unit, Department of Internal Medicine, University of Ioannina, Greece
,
Themis Kalmantis Second Department of Internal Medicine (Hem/Onc), National and Kapodistrian University of Athens, Ippokration General Hospital, Athens, Greece
,
George Christopoulos First Department of Internal Medicine, Konstantopoulio General Hospital, Nea Ionia, Greece
,
Garyfallia Kokkinis Hematology Laboratory, Sismanoglion Hospital, Melissia, Attica, Greece
,
Ilias Mihalakeas First Department of Internal Medicine, 401 Army Hospital, Athens, Greece
&
Antonios Papayiannis Hematology Section, Hygeia Hospital, Athens, Greece
 show all
Pages 635-644 | Published online: 01 Jul 2009

  • McKelvey, K.M., Gottlicb, J.A., Wilson, U.E., Haut, A., Talley, R.W., Stephens, R., Lane, M., Gamble, J.E. Jones, S.E., Grozea, P.N., Gutterman, J., Coltman, C. and Moon, T.E. (1976) "Hydroxyldaunomycin (Adrianiycin) combination chemotherapy in malignant lymphoma". Confer 38, 1484-1493.
  • Hagberg, H., Bjorkhulm, M., Glimclius, B., Lindemalni, C., Mellstedt, H. and Killander, A. (1985) "CHOP versus MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trial". European Journal of Cancer Clinical Oncology 21, 175-179.
  • WoIf, M., Matthews, J.P, Stone, J. Cooper, I.A, Rohertson, T.I. and Fox, R.M. (1997) "Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma The Australian and New Zealand Lymphoma Group". Annals of Oncology 8(Suppl. 1), 71-75.
  • Gordon, L.I., Harrington, U., Andersen, J., Colgan, J., Glick, J., Neiman, R., Mann, R., Resnick, G.D., Barcos, M., Gottlieb, A. and O' Connell, M. (1992) "Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma". New England Journal of Medicine 327, 1342-1349.
  • Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma". Annals of Internal Medicine 102, 596-602.
  • Miller, T.P., Dahlberg, S., Weick, J.K., Files, J.C., Eyre, H.J., Pendergrass, K.B. and Fisher, R.I. (1990) "Unfavoiable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study". Journal of Clinical Oncology 8, 1951-1958.
  • Cancllos, G.P., Skarin, A.T, Klatt, M.M., Rosenthal, D.S., Case, Jr., D.C., Pinkus, G.S., Jochclson, M.S., Yeap, B.Y. and Shipp, M.A. 11987) "The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma". Seminars in Hematology 24(Suppl. 1). 2-7.
  • Lungo, D.L., De Vila, Jr., V.T., Duttey, P.L. Wesley, M.N., Ihde, D.C., Hubbiiru, S.M., Gilliom, M., Jaffe, E.S., Cossman, J. and Fisher, R.I. (1991) "Superiority of ProMACE-CytaBOM over ProMACF.-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial". Journal of Clinical Oncology 9, 25-38.
  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Click, J.H., Coltman, Jr., CA. and Miller, T.P. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma". New- England Journal of Medicine 328, 1002-1006.
  • The International non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma". New England Journal of Medicine 329, 987-994.
  • Shipp, M.A., Neuberg, D., Janicek, M., Cancllos, O.P. and Shulman, L.N. (1995) "High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma; a dosefinding pilot study". Journal of Clinical Oncology 13, 2916-2923.
  • Coltman, Jr., C.A., Coltman, T.M., Balcerzak, S.P., Morrison, F.S. and Von HoIf, D.D. (1984) "Mitoxantrone in refractory non Hodgkin's lymphoma A Southwest Oncology Group study". Seminars in Oncology 11(3 Suppl. 1). 50-53.
  • Silver, R.T., Case, Jr. D.C., Wheeler, R.H., Miller, T.P., Stein, R.S., Stuart, J.J., Peterson, B.A., Rivkin, S.E., Golomb, H.M., Cosiauzi, J.J., Erslev, A.J., Reisman, A. and Dugan, M. (1991) "Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease". Journal of Clinical Oncology 9, 754-761.
  • Angelopoulou, M.K., Lafioniatis, S.N. and Pangalis, G.A. (1994) "Low grade non-Hodgkin's lymphomas: disease control with mitoxanthrone monotherapy in patients refractory to conventional therapy". Leukemia and Lymphoma 12, 253-257.
  • Gaynor, E.R., Dahlberg, S. and Fisher, R.I. (1994) "Factors affecting reduced survival of the elderly with intermediate and high grade lymphoma: an analysis of SWOG 8516 (Int 0067)--the national high priority lymphoma study--a randomised comparison of CHOP vs m-BACOD vs ProMACE-CytaBOM vs MACOP-B". Proceedings of American Society of Clinical Oncology 13, 370.
  • Gherlinzoni, F., Guglielmi, C. Mazza, P., Amadori, S., Mandelli, F. and Tura, S. (1990) "Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage Il to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology". Seminars in Oncology 17(6 Suppl. 10), 3-9.
  • Sonneveld, P. and Michiels, J.J. (1990) "Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen". British Journal of Cancer. 105-108
  • Ho, A., Del Valle, F., Ruckle, H., Schwammborn, J., Schlimok, G., Hiddemann, W., Meusers, P., Thiel, E., Dorken, B. and Hunstein, W. (1989) "Mitoxantrone and high-dose cytarabine as salvage therapy tor refractory non-Hodgkin's lymphoma". Cancer 64, 1388-1392.
  • Brusamolino, E., Bertini, M., Guidi, S., Vitolo, U., Inverardi, D., Merante, S., Colombo, A., Resegotti, L., Bernasconi, C., Ferrini, P.R., Cametti, G. and Canta, M. (1988) "CHOP versus CNOP (N Mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity". Haemaiolugica 73, 217-222.
  • Saletan, S.L. (1987) Mitoxantrone: Cardiotoxicity Abstract of the first Nordic Novantrone Symposium, Stockholm. 34-35.
  • Benneti, J.M., Muss, H.B., Dorosliow, J.H., Wolff, S., Krementz, E.T., Cartwright, K., Dukart, G., Reisman, A. and Schoch, I. (1988) "A randomized multicenter trial comparing mitoxuntrone. cyclophosphamide. and fluorouracil with doxorubicin. cyctophosphamide. and fluorouracil in the therapy of metaslatic breast carcinoma". Journal of Clinical Oncology 6, 1611-1620.
  • Posner, L.E., Dukart, G., Goldberg, J., Bernstein, T. and Cartwright, K. (1985) "Mitoxantrone: An overview of safety and toxicity". Investigational New Drugs 3, 123-132.
  • Bezwoda, W., Rastogi, R.B., Erazo VaIla, A., Diaz-Maqueo, J.C., Pavlovsky, S., Morioka, H, Resegoni, L., Rueckle, H., Somoza, N., Moreno-Nogueira, J.A., Bernasconi, C., Ho, A., Bums, I., Lardinois, J., van der Merwe, A., Richards, E. and the Novantrone International Study Group (1995) "Lung-term results of a multicentre randomized, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and highgrade non-Hodgkin's Iymphomas". European Journal of Cancer 31, 903-911.
  • Sonneveld, P., de Ridder, M., van der Lelie, H., Nicuwenhuis, K., Schauten, H., Mulder, A., van Reijswoud, I. and Lowenberg, B. (1995) "Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy", Journal of Clinical Oncology 13, 2530-2539.
  • Kimura, I., Ohnoshi, T., Masaoka, T., Sainpi, K. and Namha, K. (1986) "A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary' result". Gan To Kagaku Rvoho-Japanese Journal of Cancer Chemotherapy 13, 2813-2819.
  • Chuang, M.W., Tzeng, C.H., Chiou, T.J., Chiu, C.F. Hsieh, R.K., Liu, J.H. and Chen, P.M. (1988) "A comparative trial of C-novantrone-OP (CNOP) vs C-adriainycin-OP (CHOP) in the treatment of stage II-IV malignant lymphoma the preliminary report". Zhonghua Yi Xue Za Zhi (Taipei) 41, 51-56.
  • Economopoulos, T., Dimopoulos, M.A., Mellou, S., Pavlidis, S., Samantas, E., Nicolaides, C., Tsatalas, C., Papadopoulos, A., Papageorgiou, E., Papasavvas, P. and Founrzilas, G. (2002) "Treatment of intermediate and high grade non-Hodpkin's lymphoma using CEOP versus CNOP". European Jaurnal of Haematology 68, 135-143.
  • Guglielmi, C., Gherlinzoni, F., Amadori, S., Mazzu, P., Mantovani, L., Lauria, F., Manelli, M., Zinzani, P.L., Greco, V., Poletti, G., Gherardi, S., Mandelli, F. and Tura, S. (1989) "A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage Il-IV diffuse non-Hodgkin's lymphomas". Haematologica 74, 563-569.
  • Mainwaring, P.N., Cunningham, D., Gregory, W., Hoskin, P., Hancock, B., Norton, A.J., MacLennan, K., Smith, P., Hudson, G.V. and Linch, D. (2001) "Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with highgrade lymphoma results of a BNL1 randomized trial of PAdriaCEBO versus PMitCEBO". Blood 97, 2991-2997.
  • Zinzani, P.L., Storti, S., Zaccaria, A., Moretti, L., Magagnoli, M., Pavone, E., Gentilini, P., Guardigni, L., Gobbi, M., Fattori, P.P., Falini, B., Lauta, V.M., Bendandi, M., Gherlinzoni, F., De Renzo, A., Zaja, F. Mazza, P., Volpe, E., Bocehia, M., Aitim, E., Tabanelli, M., Leone, G. and Tura, S. (1999) "Elderly aggressive-histology non-Hodgkin's tymphoma: first-line VNCOP-B regimen experience on 350 patients". Blood 94, 33-38.
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and a description of a working formulation for clinical usage". Cancer 49, 2112-2135.
  • Carbone, P.P., Kaplan, H.S., Musshof, K., Smithers, D.W. and Tubiana, M. (1971) "Report on the Committee on Hodgkin's disease staging classification". Cancer Research 3, 1860-1861.
  • Gottlieb, J.A., Gutterman, J.A., McCredie, K.B., Rodriguez, V. and Frei, 3rd. E. (1973) "Chemotherapy of malignant lymphoma with adriamycin". Cancer Research 33, 3024-3028.
  • Hryniuk, W.M. and Goodyear, M. (1990) "The calculation of received dose intensity". Journal of Clinical Oncology 8. 1935 1937.
  • Lepage, E., Gisselbrecht, C., Haioun, C., Sebban, C., Tilly, H., Bosly, A., Morel, P., Herbrecht, R., Reyes, F. and Coiffier, B. (1993) "Prognostic significance of received relative dose intensity in nonHodgkin's lymphoma patients: application to LNH-87 protocol". Annals of Oncology 4, 651-656.
  • Miller, A.B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) "Reporting results in cancer treatment". Cancer 47, 207-214.
  • Armitage, P. and Berry, G. (1987) Statistical methods in medical research, 2nd Ed (Blackwell Scientific Publications. Oxford. England).
  • Kaplan, E. and Meier, P. (1958) "Non-parametric estimation from incomplete observations". Journal of American Statistical Association 53, 457-481.
  • Mantel, N. (1966) "Evaluation of survival data and two new rank order statistics arising in its consideration". Cancer Chemotherapy Reports 50, 163-170.
  • Cox, D.R. (1972) "Regression models and life tables". Journal of Royal Statistical Society 34, 187-220.
  • Giles, F.J., Shan, J., Advani, S.H., Akan, H., Aydogdu, I., Aziz, Z., Azim, H.A., Bapsy, P.P., Buyukkececi, F., Chaimongkol, B., Chen, P.M., Cheong, S.K., Ferhanoglu, B., Ilamza, R., Khalid, H.M., Intragumtomchai, T., Kim, S.W., Kim, S.Y., Koc, H., Kumar, L., Kumar, R., Lei, K.I., Lekhakula, A., Muthalib, A., Patel, M., Poovalingam, V.R. Prayoonwiwat, W., Rana, F., Reksodiputro, A.M., Ruff, P., Sagar, T.G., Schwarer, A.P., Song, U.S., Suh, C.W., Suharti, C., Supindiman, I., Tee, G.Y., Thamprasit, T., Villalon, A.H., VVickham, N.R., Wong, J.E., Yalcin, A., Jocrtar, S. and the Intranational Oncology Study Group NIIL1 Study (2000) "A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NIlL1 Study". Leukemia and Lymphoma 40, 95-103.
  • Aviles, A., Cleto, S., Huerta-Guzinan, J. and Neri, N. (2001) "Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOPBLEO regiments". European Journal of Haematolagy 66, 94-99.
  • Gribabis, D.A., Vassilakopoulos, T.P., Boussiotis, V.A., Kontopidou, K, Kittas, Ch., Fessas, Ph. and Pangalis, G.A. (1996) "Salvage therapy of non-Hodgkin's lymphoma with mitoxantrone. etoposide. vinblasline. bleomycin and prednisone (NVVBP) combination", British Journal of Haematology 93(Suppl 2), 369.
  • Linassier, C., Barin, C., Calais, G., Letortorec, S., Bremond, J.-L., Delain, M., Petit, A., Oeorget, M.-T., Cartion, G., Raban, N., Benboubker, L., Leloup, R., Binet, C., Lamagnere, J.-P. and Colombai, P. (2000) "Early secondary acute myelogcnous leukemia in breast cancer patients after treatment with mitoxantrone. cyclopliosphamide, fluorouracil and radiation therapy". Annals of Oncology 11, 1289-1294.
  • Hossfeld, O.K. (2000) "Mitoxantrone-related acute myelucytic leukemias", Annuls of Oncology 11, 1215-1216.
  • Chaplain, G., Milan, C., Sgro, C., Carli, P.M. and Bonithon-Kopp. C. (2000) "Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study". Journal of Clinical Oncology 18, 2836-2842.
  • Santoro, A., Balzarotti, M., Tondini, C., Zanini, M., Giardini, R., Latteri, F., Rampinelli, I. and Bufalino, R. (1999) "Dose-escalation of CHOP in non-Hodgkin's lymphoma", Annals of Oncology 10, 519-525.
  • Itoh, K., Ohtsu, T. Wakita, H., Igarashi, T., Ishizawa, K., Onozawa, Y., Fujii, H., Minami, H. and Sasaki, Y. (2000) "Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma". Annals of Oncology 11, 1241-1247.
  • Banlett, N.L., Petroni, G.R., Parker, B.A., Wagner, N.D., Gockerman, J.P., Omura, O.A., Canellos, G.P., Cooper, M.R., Johnson, J.L. and Peterson, B.A. (2001) "Dose-escalated cyclophosphamide. doxorubicin, vincristine, prednisone. and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma". Cancer 91, 207-217.
  • Pfreundschuh, M., Trumper, L., Kloess, M., Schmitz, N., Glass, B., Schmits, R., Engert, A., Rudolph, C., Illiger, J., Hossfeld, D. and Loeffler, M. (2002) "CHOEP (CHOP + Etoposide) is the new standard regimen for young patients with low risk (low LDH) aggressive non-Hodgkin's lymphoma". Annals of Oncology 13(Suppl. 2), 74.
  • Haioun, C., Lepage, E., Gisselbrecht, C. Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C. Tilly, E., Lederlin, P., Sebban, C., Briere, J., Gaulard, P. and Reyes, E. (2000) "Survival benefit of high-dose therapy in poor risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-a Groupe d' Etude des Lymphomes de I' Adulte study". Journal of Clinical Oncology 18, 3025-3030
  • Mounier, N., Haioun, C., Cole, B.E. Gisselbrecht, C., Sebban, C., Morel, P., Marit, G., Bouabdallah, R., Ravoct, C., Salles, G., Reyes, F. and Lepage, E. (2000) "Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission Groupe d'Etude les Lymphomes de l' Adulte (GELA)". Blood 95, 3687-3692.
  • Milpied, N., Deconninck, E., Colombut, Ph., lfrah, N., Delwail, V., Berthou, C., Gressin, R., Lamy, T., Jaubert, J., Casassus, Ph., Le Maignan, C., Maisonncuve, H., Ramee, J.F., Lemevel, A, Jardel, H., Desablens, B. and Harousseau, J.L. (2002) "Frontline high dose chemotherapy with aulologous stem cell transplantation vs standard CHOP regimen for patients (4 60 yo) with non-IPI high-risk intermediate or high grade lyrmhomas. Final results of a randomised trial by GOELAMS", Annuls of Oncology 13 (Suppl. 2). 28.
  • Linch, D.C., Yung, L., Smith, P., Maclennan, K., Jack, A., Hancock, B., Cunninghani, D., Hoskin, P., Holte, H., Boesen, A.M., Grigg, A. and Browett, P. (2002) "A randomised trial of CHOPx6-8 vs CHOPx3 + BEAM + ASCT in 457 patients with poor prognosis histologically aggressive non-Hodgkin's lymphoma". Annuls of Oncology 13(SuppI. 2). 28.
  • Vitolo, U., Liberati, A.M., Lambertenghi Deliliers, G., Calvi, R., Baldini, L., Bertini, M., Boccomini, C., Brugiatelli, M., Cabras, M.U., Di Renzo, N., Federico, M., Freilone, M., Levis, A., Parvis, G., Pavone, E., Pregno, P., Petrini, P., Sborgia, M., Todescbini, G., Trottini, M. and Gallo, H. (2002) "High dose chemotherapy with autologous stem cell transplantation vs intensified chemotherapy MegaCEOP in high risk diffuse large cell lymphoma: An update of a mullicenter randomized trial by Italian Lymphoma Intergroup". Annals of Oncology 13(Suppl. 2). 29.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., van den Neste, E., Salles, G., Gaulard, P., Reyes, F. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus ntuxiniab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", New England Journal of Medicine 346, 235-242.
  • Pfreundschuh, M., Trumper, L., Kloess, M., Schmilz, N., Glass, B., Schmits, R., Engert, A., Rudolph, C., Illiger, J., Hossfeld, D. and Loeffler, M. (2002) "2-weekly CHOP (CHOP-14.): the new standard regimen for patients with aggressive non-Hodgkin's lymphoma >60 years of age". Annals of Oncology 13(Suppl. 2). 27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.